Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
40.29
+0.39 (0.98%)
Jan 17, 2025, 4:00 PM EST - Market closed
Revolution Medicines Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$65.15
Upside
+61.70%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $65 → $71 | Strong Buy | Maintains | $65 → $71 | +76.22% | Jan 8, 2025 |
| Wedbush | Wedbush | Buy Maintains $70 → $67 | Buy | Maintains | $70 → $67 | +66.29% | Dec 6, 2024 |
| Needham | Needham | Strong Buy Maintains $68 → $62 | Strong Buy | Maintains | $68 → $62 | +53.88% | Dec 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $64 → $72 | Strong Buy | Maintains | $64 → $72 | +78.70% | Dec 4, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $82 → $87 | Strong Buy | Maintains | $82 → $87 | +115.93% | Dec 3, 2024 |
| Needham | Needham | Strong Buy Reiterates $68 | Strong Buy | Reiterates | $68 | +68.78% | Dec 3, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $63 → $71 | Buy | Maintains | $63 → $71 | +76.22% | Dec 3, 2024 |
| Wedbush | Wedbush | Buy Maintains $59 → $70 | Buy | Maintains | $59 → $70 | +73.74% | Nov 7, 2024 |
| Needham | Needham | Strong Buy Maintains $61 → $68 | Strong Buy | Maintains | $61 → $68 | +68.78% | Nov 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $62 → $64 | Strong Buy | Maintains | $62 → $64 | +58.85% | Nov 7, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $54 → $63 | Buy | Maintains | $54 → $63 | +56.37% | Nov 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $57 → $70 | Buy | Maintains | $57 → $70 | +73.74% | Nov 7, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $72 → $82 | Strong Buy | Maintains | $72 → $82 | +103.52% | Oct 28, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $55 → $60 | Buy | Maintains | $55 → $60 | +48.92% | Oct 28, 2024 |
| Needham | Needham | Strong Buy Reiterates $61 | Strong Buy | Reiterates | $61 | +51.40% | Oct 28, 2024 |
| Needham | Needham | Strong Buy Reiterates $61 | Strong Buy | Reiterates | $61 | +51.40% | Oct 25, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.